STAGE III LUNG CANCER AJCC V8
Clinical trials for STAGE III LUNG CANCER AJCC V8 explained in plain language.
Never miss a new study
Get alerted when new STAGE III LUNG CANCER AJCC V8 trials appear
Sign up with your email to follow new studies for STAGE III LUNG CANCER AJCC V8, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for tough lung cancers: drug combo trial launches
Disease control Not yet recruitingThis study tests a new two-drug combination for people with advanced non-small cell lung cancer that has worsened after standard treatments like chemotherapy and immunotherapy. The drugs, SX-682 and atezolizumab, work together to help the immune system attack cancer cells. About …
Matched conditions: STAGE III LUNG CANCER AJCC V8
Phase: PHASE2 • Sponsor: University of Washington • Aim: Disease control
Last updated Jun 18, 2026 11:46 UTC
-
New combo therapy targets hard-to-treat lung cancer mutation
Disease control Not yet recruitingThis study tests whether adding a cancer vaccine (CIMAVAX-EGF) to standard targeted drugs (sotorasib or adagrasib) can help control advanced lung cancer with a KRAS G12C mutation. About 29 adults with stage III or IV non-small cell lung cancer will receive the combination. The go…
Matched conditions: STAGE III LUNG CANCER AJCC V8
Phase: PHASE2 • Sponsor: Roswell Park Cancer Institute • Aim: Disease control
Last updated Jun 16, 2026 12:50 UTC
-
Could a cheaper, Lower-Dose immunotherapy work just as well for advanced cancers?
Disease control Not yet recruitingThis study tests whether giving a lower dose of the immunotherapy drug nivolumab less often can still control advanced cancers that have spread or cannot be removed. About 50 adults with various cancers (like melanoma, lung, or kidney cancer) will receive the treatment. The goal …
Matched conditions: STAGE III LUNG CANCER AJCC V8
Phase: PHASE2 • Sponsor: Fred Hutchinson Cancer Center • Aim: Disease control
Last updated Jun 15, 2026 18:56 UTC
-
Spinal tap could spot brain metastases early in lung cancer patients
Knowledge-focused Not yet recruitingThis study tests whether a lumbar puncture (spinal tap) can find tumor DNA in the fluid around the brain and spine of people with stage III or IV non-small cell lung cancer. The goal is to see if this test can help predict which patients will develop brain metastases. About 40 pa…
Matched conditions: STAGE III LUNG CANCER AJCC V8
Phase: NA • Sponsor: Ohio State University Comprehensive Cancer Center • Aim: Knowledge-focused
Last updated Jun 16, 2026 12:52 UTC